Alterity Therapeutics Files 6-K with Options Prospectus
Ticker: PRNAF · Form: 6-K · Filed: Apr 17, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, prospectus
TL;DR
Alterity Therapeutics filed a 6-K with an options prospectus, likely for employee or investor equity plans.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on April 17, 2025, to incorporate by reference into its existing Registration Statements on Form S-8 and Form F-3. The filing includes an Options Prospectus as Exhibit 99.1.
Why It Matters
This filing is procedural, incorporating an options prospectus into existing SEC registration statements, which is relevant for investors tracking the company's equity offerings and potential dilution.
Risk Assessment
Risk Level: low — This is a routine filing to incorporate documents into existing registration statements, not indicating new material events or financial distress.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- April 17, 2025 (date) — Filing Date
- Form S-8 (document) — Incorporated by reference into
- Form F-3 (document) — Incorporated by reference into
- Options Prospectus (document) — Exhibit 99.1
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being filed to incorporate by reference into Alterity Therapeutics Limited's existing Registration Statements on Form S-8 and Form F-3.
What specific document is included as an exhibit with this filing?
Exhibit 99.1, an Options Prospectus, is submitted with this Form 6-K.
Which SEC registration statements is this 6-K being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics Limited's Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Does Alterity Therapeutics file annual reports under Form 20-F or Form 40-F?
Alterity Therapeutics indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 17, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).